Remove 2019 Remove Diabetes Remove DO Remove Electronics
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. mg or placebo in 2019. Both the FDA and EMA recommend that doctors monitor patients with diabetic retinopathy who are undergoing semaglutide treatment closely. semaglutide 1.0

Diabetes 130
article thumbnail

Churning out of insurance among patients with diabetes served in US Community Health Centers [Economic or policy analysis]

Annals of Family Medicine

Health insurance instability may be particularly challenging for patients with diabetes who need regular chronic care management to reduce the risk of diabetes complications. 46,844 patients were diagnosed with diabetes during study period. 46,844 patients were diagnosed with diabetes during study period.

article thumbnail

Automatic Detection of Osteoporosis in Electronic Consultation (eConsult) Service Using Natural Language Processing [Health care informatics]

Annals of Family Medicine

Population Studied Population is a sample of the 2019-20 of endocrinology cases off the Champlain eConsult BASE™ system. Setting or Dataset Out of 844 size sample of endocrinology cases, our human expert annotated only 144 as true osteoporosis cases, flagged as a binary target. We took a random sample of 144 endo cases as non-osteo.